Recent sales
Desitin is demonstrating the success of the company’s strategy by showing that more than 90 % of its sales are in CNS therapeutic areas and by achieving a growth of 13 % (in Germany) respectively 7 % (internationally) in the total annual sales of their latest new products already within the first year of their launch.
)
(Please click on the picture to zoom)
)
(Please click on the picture to zoom)
